Autolus Therapeutics FY2026 AUCATZYL net product revenue expected to be more than $150.000M

Benzinga · 2d ago

Autolus Therapeutics (NASDAQ:AUTL) FY2026 AUCATZYL net product revenue expected to be more than $150.000M.